Idiopátiás tüdőfibrózis: vizsgálatok itt: Dánia
11 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 14.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleStudy to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis
- Where
- Aarhus N, Hellerup, Odense C
- Életkor
- 40 év and over
- People
- 324 worldwide
- Run by
- Contineum Therapeutics
See details and how to joinNCT07284459 · EU 2025-521901-42-00 - 2. fázisTaking peopleA Phase IIb Study to Evaluate AZD8965 in Participants with Idiopathic Pulmonary Fibrosis (IPF)
- Where
- Aarhus N, Copenhagen Oe, Hellerup, Odense C
- Életkor
- 18 év and over
- People
- 139 worldwide
- Run by
- AstraZeneca AB
See details and how to join2025-525016-41-00 - 2. fázisTaking peopleSenicapoc in Patients With Worsening Fibrotic Interstitial Lung Disease
- Where
- Aarhus N, Copenhagen
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Vejle Hospital
See details and how to joinNCT06714123 · EU 2024-511131-97-00 - 3. fázisNot yet taking people in DániaLong-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis
- Where
- Copenhagen Oe, Hellerup, Odense C
- Életkor
- 18 év and over
- People
- 2380 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07441408 · EU 2025-522373-10-00 - 2. fázisTaking peopleA Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
- Where
- Aarhus, Copenhagen, Hellerup, Odense C
- Életkor
- 40 év and over
- People
- 359 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07652658 - 3. fázisNot yet taking people in DániaTrial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
- Where
- Aarhus N, Odense C
- Életkor
- 40 év and over
- People
- 1100 worldwide
- Run by
- PureTech
See details and how to joinNCT07284602 · EU 2025-524493-42-00 - 3. fázisCsak meghívásosExtension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
- Where
- Aarhus N, Hellerup, Odense C
- Életkor
- 40 év and over
- People
- 1850 worldwide
- Run by
- United Therapeutics
See details and how to joinNCT04905693 - 3. fázisFut, nem toborozA Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Idiopathic Pulmonary Fibrosis
- Where
- Aarhus N, Hellerup, Odense C
- Életkor
- 18 év and over
- People
- 239 worldwide
- Run by
- Bristol-Myers Squibb Services Unlimited Company
See details and how to join2023-503697-21-01 - 3. fázisFut, nem toborozA Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis
- Where
- Copenhagen Oe, Hellerup, Odense C
- Életkor
- 18 év and over
- People
- 249 worldwide
- Run by
- Bristol-Myers Squibb Services Unlimited Company
See details and how to join2023-503699-25-00 - No phaseNot yet taking people in DániaPRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
- Where
- Aarhus
- Életkor
- 18 év to 80 év
- People
- 500 worldwide
- Run by
- University of Massachusetts, Worcester
See details and how to joinNCT06855329 - No phaseTaking peopleCohort of IPF Patients Experiencing an Exacerbation
- Where
- Hellerup
- Életkor
- 18 év and over
- People
- 50
- Run by
- University Hospital, Gentofte, Copenhagen
See details and how to joinNCT04442711